查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1549708

药品包装：市场占有率分析、产业趋势与统计、成长预测（2024-2029）

Pharmaceutical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 201 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药品包装市场规模预计到2024年为1,021亿美元，预计到2029年将达到1,372.8亿美元，在预测期内（2024-2029年）复合年增长率为6.10%。

医药包装市场

主要亮点

  • 製药业在全球范围内不断发展，产生了对治疗传染性和非传染性疾病的包装的需求。因此，对保护药品免受损坏、生物污染和外部影响的包装的需求不断增长。
  • 药品需求的成长与产业技术进步有关，这直接创造了对瓶子、管瓶和其他包装解决方案的需求。此外，对注射剂的需求不断增长正在推动製药业管瓶的成长。对癌症药物和其他高药理活性药物（例如抗体偶联物和速效类固醇）的强劲需求以及人均药物支出的增加预计将成为关键驱动因素。
  • 全球药品需求情境支持了包装产业的产生收入，预计在预测期内将持续下去。总体而言，由于药品包装的不断扩张和研发改进，药品包装市场预计将录得稳定成长。因此，预计在预测期内需求将大幅增加。
  • 塑胶包装产业正面临聚合物成本上涨的问题，使得塑胶变得更加昂贵。此外，乌克兰和俄罗斯之间的战争正在再次推高价格。塑胶及塑胶製品的需求逐年增加。供不应求跟上不断增长的需求也是聚合物价格上涨的一个因素，预计将阻碍市场成长。
  • 由于 COVID-19 的传播，预计该市场将大幅成长。由于新冠肺炎 (COVID-19) 疫情的爆发，顾客已转向线上购买。 COVID-19大流行对开发中国家的包装材料扩张造成了重大打击。然而，对无菌药品包装的强劲需求鼓励了对该领域的投资。此外，业内相关人员预计医疗产业对封装技术将表现出强劲的需求。

医药包装市场趋势

塑胶包装占有很大的市场占有率

  • 塑胶是最受欢迎的药品包装材料之一，因为它用途广泛、耐用、灵活且永续。药品包装使用由多种材料製成的塑胶瓶，包括聚氯乙烯、聚乙烯、聚丙烯和聚苯乙烯。该行业使用透明、耐用且轻质的塑料来储存和分配。
  • 塑胶用于包装泡壳包装、小袋、预填充式注射器和吸入器、注射液袋和瓶子。用于药品包装的材料必须具有化学惰性、水蒸气渗透性低且易于处理。此外，包装材料与药品和生物製药直接接触，必须遵守监管机构的严格规定。塑胶和聚合物满足这些要求，因此经常用于药品包装。
  • 药品包装瓶由防儿童开启的瓶盖和封口组成。美国FDA要求药用塑胶製造商在产品标籤上标示「儿童安全包装」声明，以获得消费者认可。对儿童安全包装的需求不断增长是预测期内推动医药塑胶包装市场的因素之一。
  • 作为利用药品包装的一部分，公司正专注于扩大业务。例如，2024 年 9 月，德国医疗保健包装公司 Sanner 公布了位于本斯海姆的新生产基地和新总部蓝图。 Sanner 专注于固态药品塑胶包装和液体初级包装，处于製药领域干燥剂包装发展的前沿。此举旨在扩大其在该地区的影响力，并有望促进该行业的成长。
  • 此外，聚氯乙烯和 PVDC（聚偏二氯乙烯）通常用作主要包装材料，可保护药品免受氧气、异味、湿气、水蒸气穿透、污染和细菌的影响。这使得 PVC 和 PVDC 成为泡壳包装的合适材料。其卓越的有机品质确保包装食品和药品的风味不受影响。 PVC 单膜可抵抗阳光和紫外线，在製造和分销过程中抑制细菌的生长，并可作为防止污染的屏障。

亚太地区占主要份额

  • 中国医药产业的强劲成长为该国医药包装公司创造了庞大的商机。对于企业来说，探索满足药品包装市场新需求的包装概念变得非常重要。
  • 中国政府加速医疗体系转型的政策预计将加速医药包装产业的发​​展。此外，我国正积极升级医药包装设备和材料，实现医药产品多元化，为医药包装企业创造了新的机会。
  • 受製药业成长和新兴经济体医疗保健服务改善的推动，日本药品包装市场的前景看好。塑胶、玻璃、纸张和铝箔是该市场的主要材料。直接影响药品包装产业动态的新兴趋势包括对环保包装的需求不断增长、奈米包装的使用增加以及吹灌封技术的日益采用。
  • 印度药品包装产业在过去几年中取得了显着成长。随着科技创新和新疗法的出现，製药业这一领域还有进一步成长的空间。 COVID-19 大流行增强了高效包装和分销产品的需求。我们可能会期望更快地製造和分销产品，甚至包括包装。包装公司将面临新的压力，需要加快速度并开发增加需求的解决方案。
  • 韩国是亚洲成长最快的製药地区之一，并正在成为全球医疗保健创新的关键贡献者。韩国近年来在新药研发方面取得了快速进展。特别是近年来，韩国的新药研发能力在全球医药和生技产业中处于领先地位。
  • 亚太地区的其他国家包括印尼、澳洲、新加坡、泰国和马来西亚等几个国家。该市场的推动因素包括国际合作伙伴关係的激增、生物相似药的成长、成品出口以及强劲的学名药市场。

医药包装行业概况

在医药包装市场，现有企业之间的竞争非常激烈。该市场较为分散，Amcor PLC、Schott AG、WestRock Company、Berry Global 和 Aptar Group Inc. 等多家主要公司均参与其中。公司正在透过产品发布、合作伙伴关係和投资来扩展业务。

  • 2024 年 5 月，医药塑胶包装领域的主要企业Gerresheimer AG 宣布计画收购 Bormioli Pharma。这项策略性倡议旨在将 Bormioli Pharma 的专业产品（例如双室和儿童防护/TE 瓶盖配件）整合到 Gerresheimer 的产品组合中，并加强其在药品包装领域的影响力。
  • 2024 年 1 月 Bormioli Pharmaceuticals 很快就会成为 Gerresheimer AG 的一部分，并与洁净科技公司 Loop Industries 合作。为了满足对永续包装日益增长的需求，该合作伙伴关係旨在提供专门由 Loop PET 树脂製成的包装，这是一种源自回收资源的高品质材料。此举凸显了医药包装领域对PET材料不断增长的需求。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场洞察

  • 市场概况
  • 产业价值链分析
  • 产业吸引力－波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度
  • COVID-19 市场影响评估

第五章市场动态

  • 市场驱动因素
    • 包装监管标准和打击仿冒品的严格规范
    • 奈米技术对新一代创新包装解决方案的影响
  • 市场挑战
    • 由于供应商议价能力而导致原物料成本波动

第六章 市场细分

  • 按材质
    • 塑胶
    • 玻璃
    • 其他材料
  • 依产品类型
    • 瓶子
    • 注射器
    • 管瓶/安瓿
    • 管子
    • 盖子和塞子
    • 标籤
    • 其他产品类型
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 韩国
      • 其他亚太地区
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲
    • 中东/非洲
      • 阿拉伯聯合大公国
      • 沙乌地阿拉伯
      • 南非
      • 其他中东和非洲

第七章 竞争格局

  • 公司简介
    • Amcor PLC
    • 3M Company
    • Schott AG
    • WestRock Company
    • Berry Global Group Inc.
    • McKesson Corporation
    • AptarGroup Inc.
    • Klockner Pentaplast Group
    • CCL Industries Inc.
    • FlexiTuff International Ltd
    • Gerresheimer AG
    • West Pharmaceutical Services Inc.
    • Becton, Dickinson and Company
    • Vetter Pharma International GmbH
    • Catalent Inc.
    • WL Gore & Associates Inc.
    • Nipro Corporation

第八章投资分析

第九章 市场机会及未来趋势

简介目录
Product Code: 53455

The Pharmaceutical Packaging Market size is estimated at USD 102.10 billion in 2024, and is expected to reach USD 137.28 billion by 2029, growing at a CAGR of 6.10% during the forecast period (2024-2029).

Pharmaceutical Packaging - Market

Key Highlights

  • The pharmaceutical industry is growing worldwide, creating a need for packaging to treat communicable and non-communicable diseases. Therefore, the demand for packaging in pharmaceutical manufacturing is growing as it protects pharmaceuticals from damage, biological contamination, and external influences.
  • Increased demand for pharmaceuticals is associated with technological advancements in the industry and directly creates demand for bottles, vials, and other packaging solutions. Additionally, the growing demand for injectables is driving the growth of glass vials in the pharmaceutical industry. Strong demand for oncology and other high-potency drugs (such as antibody conjugates and fast-acting steroids) and increasing per capita spending on pharmaceuticals are expected to be key growth drivers.
  • The global demand scenario for pharmaceutical products has supported revenue generation in the packaging sector and is expected to continue during the forecast period. Overall, the pharmaceutical packaging market is projected to register a steady growth rate due to ongoing expansion and research and development to improve pharmaceutical packaging. Thus, demand is anticipated to increase significantly during the forecast period.
  • The plastic packaging industry faces rising polymer costs, making plastics more expensive. Additionally, the war between Ukraine and Russia has pushed prices up again. The demand for plastics and plastic products is increasing Y-o-Y. The lack of supply to keep up with the increase in demand is also one factor driving higher polymer prices, which is expected to hinder market growth.
  • Owing to the spread of COVID-19, the market is expected to grow significantly. Due to the COVID-19 pandemic, customers shifted toward online purchasing. The COVID-19 pandemic hit hard on expanding packaging materials in developing and developed countries. However, strong demand for sterilized pharmaceutical packaging encouraged investment in the landscape. Moreover, industry players expect the healthcare industry to show strong demand for packaging technology.

Pharmaceutical Packaging Market Trends

Plastic Packaging Holds a Significant Market Share

  • Plastic is one of the most popular materials for pharmaceutical packaging as it is more applicable, durable, flexible, and sustainable. Pharmaceutical packaging utilizes plastic bottles constructed from various materials, including polyvinyl chloride, polyethylene, polypropylene, and polystyrene. The industry uses transparent, durable, lightweight plastic to store and market.
  • Plastics are used for packaging blister packs, sachets, prefilled syringes and inhalers, parenteral solution pouches, and bottles. Materials used in pharmaceutical packaging need to be chemically inert, have low permeability to water vapor, and are easy to handle. In addition, packaging materials come in direct contact with pharmaceuticals and biological agents and, hence, need to comply with strict regulations from regulatory authorities. Plastics and polymers meet these requirements; therefore, they are often used in pharmaceutical packaging.
  • Bottles for pharmaceutical packaging consist of child-resistant caps and closures. The US FDA requires pharmaceutical plastic manufacturers to highlight "child-resistant packaging" on product labels for consumer evaluation. Rising demand for child-safe packaging is one of the factors driving the pharmaceutical plastic packaging market during the forecast period.
  • Companies are focused on expanding their business as part of leveraging pharmaceutical packaging. For instance, in September 2024, Germany-based healthcare packaging firm Sanner unveiled blueprints for a fresh production site and its new headquarters in Bensheim. Specializing in plastic packaging for solid medications and single-dose primary packaging for liquids, Sanner has been at the forefront of promoting desiccant packaging in the pharmaceutical realm. This move to expand its presence in the region is poised to catalyze growth in the sector under scrutiny.
  • Moreover, polyvinyl chloride and PVDC (polyvinylidene chloride), commonly used as principal packaging materials, protect pharmaceutical items from oxygen and odor, moisture, water vapor transmission, contamination, and bacteria. This makes PVC and PVDC the preferred materials for blister packing. Their superior organoleptic qualities ensure that the flavor of packaged food and medications remains unaffected. PVC mono films are sunlight and UV-ray-resistant and serve as a barrier against contamination by halting the spread of germs during production and distribution.

Asia-Pacific to Occupy Major Share

  • The robust growth of the Chinese pharmaceutical sector creates significant business opportunities for the country's pharmaceutical packaging companies. It is now becoming critical for companies to look for packaging concepts that meet emerging needs in the pharmaceutical packaging market.
  • The Chinese government's policies to accelerate the transformation of the country's medical regime are expected to promote the development of the pharmaceutical packaging sector. Furthermore, China is actively upgrading its pharmaceutical packaging facilities and materials and diversifying its pharmaceutical products, bringing new opportunities to pharmaceutical packaging firms.
  • The future of the pharmaceutical packaging market in Japan looks good, driven by the pharmaceutical industry's growth and improving healthcare services in developing economies. In this market, plastic, glass, paper, and aluminum foil are the main material types. Emerging trends directly impacting the dynamics of the pharmaceutical packaging industry include rising demand for eco-friendly packaging, increasing use of nano-enabled packaging, and increasing adoption of blow-fill-seal technology.
  • The pharmaceutical packaging industry in India has been experiencing substantial growth for several years. Due to innovations and emerging treatments, there is room for further growth in this section of the pharma industry. The COVID-19 pandemic has brought a new awareness of the need to package and distribute products efficiently. There will be expectations to manufacture and distribute products quicker, right down to the packaging. Packaging companies will face new pressures to develop solutions to get things moving faster and increase demand.
  • South Korea is one of the fastest-growing pharma regions in Asia, emerging as a critical contributor to global healthcare innovation. It has tremendously advanced new drug research and development in the last few years. Especially during the past few years, Korea has developed new drug R&D capabilities in the global pharmaceutical and biotech landscape.
  • The scope of the Rest of Asia-Pacific includes multiple countries, such as Indonesia, Australia, Singapore, Thailand, and Malaysia. The market is driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations, and a robust generics market.

Pharmaceutical Packaging Industry Overview

The rivalry among the existing players is intense in the pharmaceutical packaging market. The market is fragmented with the presence of various major players, such as Amcor PLC, Schott AG, WestRock Company, Berry Global, and Aptar Group Inc. Companies are expanding their business through product launches, collaborations, and investments.

  • May 2024: Gerresheimer AG, a key player in the pharmaceutical plastic packaging sector, announced its acquisition plans for Bormioli Pharma. This strategic move aims to integrate Bormioli Pharma's specialized offerings, such as the Dual Chamber and Child Proof / TE Closures Accessories, into Gerresheimer's portfolio, bolstering its presence in the pharmaceutical packaging landscape.
  • January 2024: Bormioli Pharma, soon to be under the ownership of Gerresheimer AG, collaborated with Loop Industries, a clean technology firm. With a goal to meet the rising need for sustainable packaging, the collaboration is offering packaging made exclusively from Loop PET resin, a high-quality material sourced from recycled sources. This move underscores the growing demand for PET materials in the pharmaceutical packaging sector.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumption and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitutes
    • 4.3.5 Degree of Competition
  • 4.4 Assessment of Impact of the COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Regulatory Standards on Packaging and Stringent Norms Against Counterfeit Products
    • 5.1.2 Impact of Nanotechnology due to Innovative and New- generation Packaging Solutions
  • 5.2 Market Challenges
    • 5.2.1 Fluctuations in Raw Material Cost Due to Suppliers Bargaining Power

6 MARKET SEGMENTATION

  • 6.1 By Material
    • 6.1.1 Plastics
    • 6.1.2 Glass
    • 6.1.3 Other Materials
  • 6.2 By Product Type
    • 6.2.1 Bottles
    • 6.2.2 Syringes
    • 6.2.3 Vials and Ampoules
    • 6.2.4 Tubes
    • 6.2.5 Caps and Closures
    • 6.2.6 Labels
    • 6.2.7 Other Product Types
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 Germany
      • 6.3.2.2 United Kingdom
      • 6.3.2.3 France
      • 6.3.2.4 Italy
      • 6.3.2.5 Spain
      • 6.3.2.6 Rest of Europe
    • 6.3.3 Asia-Pacific
      • 6.3.3.1 China
      • 6.3.3.2 Japan
      • 6.3.3.3 India
      • 6.3.3.4 South Korea
      • 6.3.3.5 Rest of Asia-Pacific
    • 6.3.4 Latin America
      • 6.3.4.1 Brazil
      • 6.3.4.2 Mexico
      • 6.3.4.3 Rest of Latin America
    • 6.3.5 Middle East and Africa
      • 6.3.5.1 United Arab Emirates
      • 6.3.5.2 Saudi Arabia
      • 6.3.5.3 South Africa
      • 6.3.5.4 Rest of Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Amcor PLC
    • 7.1.2 3M Company
    • 7.1.3 Schott AG
    • 7.1.4 WestRock Company
    • 7.1.5 Berry Global Group Inc.
    • 7.1.6 McKesson Corporation
    • 7.1.7 AptarGroup Inc.
    • 7.1.8 Klockner Pentaplast Group
    • 7.1.9 CCL Industries Inc.
    • 7.1.10 FlexiTuff International Ltd
    • 7.1.11 Gerresheimer AG
    • 7.1.12 West Pharmaceutical Services Inc.
    • 7.1.13 Becton, Dickinson and Company
    • 7.1.14 Vetter Pharma International GmbH
    • 7.1.15 Catalent Inc.
    • 7.1.16 W. L. Gore & Associates Inc.
    • 7.1.17 Nipro Corporation

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS